Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Xiaorong Dong
Huazhong University of Science and Technology
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
108
TOTAL CITATIONS
0
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Efficacy and Safety of IBI351 Monotherapy in KRASG12C-Mutated Metastatic Colorectal Cancer: Results from a Pooled Analysis of Phase I Part of Two Studies
Number of pages: 17
Posted: 15 Oct 2024
Ying Yuan
,
Yanhong Deng
,
Yongdong Jin
,
Zeng-Qing Guo
,
Yueyin Pan
,
Cunji Wang
,
Zhiwu Wang
,
Yi Hu
,
Dong Hua
,
Xiangjiao Meng
,
Zhiye Zhang
,
Mingfang Zhao
, Xiaorong Dong,
Dingzhi Huang
,
Xiaoyan Li
,
Lian Liu
,
Meili Sun
,
Huijuan Wang
,
Xiuwen Wang
,
Nong Yang
,
Mingjun Zhang
,
Sheng Hu
,
Dongde Wu
,
Jingjing Huang
,
Sujie Zhang
,
Mengna Huang
and
Ke-feng Ding
Zhejiang University, Sun Yat-sen University (SYSU), Sichuan Cancer Hospital, Fujian Medical University - Department of Medical Oncology, Anhui Provincial Hospital, Hunan Traditional Chinese Medical College, Tangshan People’s Hospital, Government of the People's Republic of China - Department of Oncology, Nanjing Medical University - Department of Oncology, Shandong Provincial Cancer Hospital, Henan University of Science and Technology, China Medical University, Huazhong University of Science and Technology, Tianjin Medical University - Tianjin Cancer Institute, Capital Medical University, Shandong University, Shandong First Medical University, Zhengzhou University, Shandong University, Central South University - Department of Medical Oncology, Anhui Medical University, Huazhong University of Science and Technology - Department of Medical Oncology, Huazhong University of Science and Technology - Hubei Cancer Hospital, Innovent Biologics (Suzhou) Co. Ltd, Innovent Biologics (Suzhou) Co. Ltd, Innovent Biologics (Suzhou) Co. Ltd and Zhejiang University - Department of Colorectal Surgery and Oncology
Downloads
69
(891,180)
View PDF
Download
Abstract:
IBI351, KRASG12C, colorectal cancer, efficacy
2.
Osimertinib after definitive chemoradiotherapy in patients with unresectable stage III EGFR-mutated NSCLC: LAURA China cohort
Number of pages: 26
Posted: 24 Dec 2025
Xiaorong Dong,
Hong Jian
,
Meijuan Huang
,
Shuanghu Yuan
,
Zhengfei Zhu
,
Lin Wu
,
Ming Chen
,
Nan Bi
,
Yi Pan
,
Yingyi Wang
,
Dongqing Lv
,
Elena Armenteros Monterroso
,
Xiangning Huang
,
Rui Mao
,
Wei Fu
,
Yi Zhao
and
Shun Lu
Huazhong University of Science and Technology, Shanghai Jiao Tong University (SJTU) - Department of Medical Oncology, Sichuan University - Department of Thoracic Oncology, Shandong First Medical University - Shandong Cancer Hospital and Institute, Fudan University - Department of Radiation Oncology, Zhengzhou University - Henan Provincial People's Hospital, Sun Yat-sen University (SYSU), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Radiation Oncology, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute,
affiliation not provided to SSRN
, Wenzhou Medical University - Affiliated Taizhou Hospital,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
and Shanghai Jiao Tong University (SJTU) - Shanghai Lung Cancer Center
Downloads
39
(1,236,159)
View PDF
Download
Abstract:
Osimertinib, Chemoradiotherapy, China, EGFR-mutated
Feedback